combination therapies outperforming semaglutide GLP-1 receptor agonism: a transformative approach for managing type-2 diabetes and obesity Tirzepatide Outperforms Semaglutide in Weight

[1] [12] These effects contribute to improved glycaemic control and often significant weight loss

It does this through several mechanisms: Appetite suppression: Semaglutide affects brain receptors responsible for hunger, reducing appetite and cravings

See our other treatments Explore other clinician-reviewed treatment programs.

It is slightly different because it is the first medication in a new class called "dual agonists." Like Wegovy, Mounjaro mimics GLP-1

Why you should (not) use semaglutide?: a critical discourse analysis on health professionals' videos of semaglutide for weight loss on Douyin

Key Considerations The oral form benefits from an enhancer, SNAC, to survive stomach conditions, whereas the injectable version bypasses digestion entirely, administered under the skin